SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY ARTICLE M impact

OncoZenge rights issue ~92% subscribed; raises ~SEK 30.7M

OncoZenge’s rights issue is preliminarily ~92% subscribed: 80% with rights and 12% without. Expected gross proceeds are ~SEK 30.7M, and the Vator Securities AB guarantee is not expected to be utilised.

ONCOZ

Preliminary outcome: OncoZenge’s rights issue is ~92% subscribed, comprising 80% with rights and 12% without, with expected gross proceeds of ~SEK 30.7M. The guarantee from Vator Securities AB is not expected to be used.

Related stories